Cumberland Pharmaceuticals Inc. (CPIX) Gross margin 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) gross margin by fiscal year — reported gross profit divided by reported revenue.
85.0%FY2025 · since FY2016: 81.7% → 85.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 85.0% | +2.4 pp |
| FY2024 | 82.6% | -2.1 pp |
| FY2023 | 84.7% | +6.4 pp |
| FY2022 | 78.3% | +3.4 pp |
| FY2021 | 74.9% | -1.0 pp |
| FY2020 | 75.9% | -1.2 pp |
| FY2019 | 77.1% | -2.0 pp |
| FY2018 | 79.1% | -2.6 pp |
| FY2017 | 81.7% | +0.1 pp |
| FY2016 | 81.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice